Literature DB >> 32446392

SIRT1 enhances hepatitis virus B transcription independent of hepatic autophagy.

Takuo Yamai1, Hayato Hikita1, Makoto Fukuoka1, Keisuke Fukutomi1, Kazuhiro Murai1, Tasuku Nakabori1, Ryoko Yamada1, Kei Miyakawa2, Kohei Watashi3, Akihide Ryo2, Takahiro Kodama1, Ryotaro Sakamori1, Tomohide Tatsumi1, Tetsuo Takehara4.   

Abstract

Autophagy is an intracellular process that can lead to the degradation of malfunctioned proteins and damaged organelles to maintain homeostasis during cellular stress. Here, we evaluated the change in hepatitis B virus (HBV) production by regulating hepatic autophagy in HBV-producing cells. We examined focusing on a relation with a positive autophagy regulator, sirtuin1 (SIRT1). Starvation and rapamycin treatment induced autophagy with increasing SIRT1 protein, HBc protein and pregenomic RNA (pgRNA) levels in HBV- producing cells. Knockdown of Atg7 or Atg13 suppressed hepatic autophagy, and it did not change SIRT1 protein, HBc protein or pgRNA levels in HBV- producing cells. Resveratrol, which increases SIRT1 expression and activity, promoted autophagy and increased HBc protein and pgRNA levels. siRNA-mediated knockdown of SIRT1 inhibited autophagy and decreased HBc protein and pgRNA levels. In SIRT1-knockdown cells, starvation promoted autophagy but did not increase HBc protein and pgRNA levels. In conclusion, HBc protein and pgRNA levels are upregulated not by the autophagic process itself but by the SIRT1 expression level.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy; HBV; Replication; Sirtuin1 (SIRT1); Transcription

Mesh:

Substances:

Year:  2020        PMID: 32446392     DOI: 10.1016/j.bbrc.2020.04.031

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Capsid Allosteric Modulators Enhance the Innate Immune Response in Hepatitis B Virus-Infected Hepatocytes During Interferon Administration.

Authors:  Keisuke Fukutomi; Hayato Hikita; Kazuhiro Murai; Tasuku Nakabori; Akiyoshi Shimoda; Makoto Fukuoka; Takuo Yamai; Yuichiro Higuchi; Kei Miyakawa; Hiroshi Suemizu; Akihide Ryo; Ryoko Yamada; Takahiro Kodama; Ryotaro Sakamori; Tomohide Tatsumi; Tetsuo Takehara
Journal:  Hepatol Commun       Date:  2021-08-25

2.  Inhibition of nonhomologous end joining-mediated DNA repair enhances anti-HBV CRISPR therapy.

Authors:  Kazuhiro Murai; Takahiro Kodama; Hayato Hikita; Akiyoshi Shimoda; Makoto Fukuoka; Keisuke Fukutomi; Satoshi Shigeno; Yuto Shiode; Daisuke Motooka; Yuichiro Higuchi; Kei Miyakawa; Hiroshi Suemizu; Akihide Ryo; Yuki Tahata; Yuki Makino; Ryoko Yamada; Ryotaro Sakamori; Tomohide Tatsumi; Tetsuo Takehara
Journal:  Hepatol Commun       Date:  2022-05-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.